Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.

Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.

Item
http://www.wikidata.org/entity/Q33157901
Long-Term Outcomes with Medications for Attention-Deficit Hyperactivity DisorderTransdermal therapy for attention-deficit hyperactivity disorder with the methylphenidate patch (MTS)Attention-deficit/hyperactivity disorder treatment: what are the long-term cardiovascular risks?Methylphenidate transdermal system: a multisite, open-label study of dermal reactions in pediatric patients diagnosed with ADHD.The single-dose pharmacokinetics of NWP06, a novel extended-release methylphenidate oral suspension.Methylphenidate transdermal system: clinical applications for attention-deficit/hyperactivity disorder.Toward quality care in ADHD: defining the goals of treatment.Safety of medicines used for ADHD in children: a review of published prospective clinical trials.Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity.The safety of extended-release drug formulations for the treatment of ADHD.New Formulations of Methylphenidate for the Treatment of Attention-Deficit/Hyperactivity Disorder: Pharmacokinetics, Efficacy, and Tolerability.Pediatric pharmacoepidemiology - safety and effectiveness of medicines for ADHD.Effects of methylphenidate on appetite and growth in children diagnosed with attention deficit and hyperactivity disorder.Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
P2860

Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.

Item
http://www.wikidata.org/entity/Q33157901
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Long-term tolerability of the ...... nsion of four clinical trials.
@ast
Long-term tolerability of the ...... nsion of four clinical trials.
@en
type
label
Long-term tolerability of the ...... nsion of four clinical trials.
@ast
Long-term tolerability of the ...... nsion of four clinical trials.
@en
prefLabel
Long-term tolerability of the ...... nsion of four clinical trials.
@ast
Long-term tolerability of the ...... nsion of four clinical trials.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Long-term tolerability of the ...... nsion of four clinical trials.
@en
P2093
P304
P31
P356
10.1016/J.CLINTHERA.2009.08.002
P433
P478
P577
P698
P921